Eisai
4523.T
#2345
Rank
A$11.24 B
Marketcap
A$39.88
Share price
-3.48%
Change (1 day)
-11.21%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.20. an increase over its 2024 EPS that were of A$1.36.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.5211.85%
2024A$1.36-32.63%
2023A$2.025.52%
2022A$1.91-74.01%
2021A$7.35-66.58%
2020A$21.9998.24%
2019A$11.0917.01%
2018A$9.4837.78%
2017A$6.88-27.62%
2016A$9.5035.33%
2015A$7.02-2.82%
2014A$7.23-27.66%
2013A$9.99-27.49%
2012A$13.78-12.67%
2011A$15.7888.08%
2010A$8.39-11.06%
2009A$9.43-390.15%
2008A-$3.25-127.78%
2007A$11.7111.78%
2006A$10.474.38%
2005A$10.037.4%
2004A$9.3443.03%
2003A$6.5325.09%
2002A$5.2252.67%
2001A$3.4269.76%
2000A$2.01